Atlas Trials

Revagenix, Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Revagenix, Inc.

RecordFirmDate
A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa (NCT07709494)Revagenix, Inc.2026-07-13

Track Revagenix, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.